Parkinson’s is a progressive neurological condition driven by the loss of dopamine-producing neurons, which causes tremors, ...

The studies also ‘offer hope’ that transplanted cells could tackle symptoms of the condition, such as tremors.

Adult stem cells can be altered to have the ... There’s no FDA-approved stem cell therapy for Parkinson’s, but clinical ...

Dr. Laura Finn brings new treatment options to Louisiana using genetically altered cells to treat blood cancer patients. Here ...

Another man can now move his arms and legs following the treatment ... pluripotent stem (iPS) cells are created by reverting adult cells to an embryonic-like state, from which they can be coaxed ...

Market Valued at US$ 1.69 Billion in 2024, Driven by Technological Advancements and Growing Healthcare Investments ...

Techniques that cause multipotent adult mesenchymal stem cells (MSCs) to differentiate ... activities in the OA joint. Targeted gene therapy might further enhance these activities of MSCs.

Cytora, a clinical stage company developing unique stem cell treatments based on human Oral Mucosa Stem Cells (hOMSCs), reported today successful results of a Phase 1/2a clinical trial for treating ...

A novel cell therapy approach using cord blood-derived natural killer (NK) cells pre-complexed with AFM13, or acimtamig, a CD30/CD16A bispecific antibody, was safe and generated strong response rates ...

He not only highlighted the success stories of using adult stem cell therapy and platelet-rich plasma therapy in treating patients with conditions such as stroke, arthritis, cerebral palsy ...

In partnership with the National Institute of Allergy and Infectious Diseases, we committed nearly $4 million over five years to co-fund a major study of mesenchymal (adult) stromal cells as a new ...

The stem cell treatment involved the injection of roughly two million reprogrammed or induced pluripotent stem (iPS) cells, which are created by hacking adult cells back into an embryonic-like state.